Company: CRNX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-029050
Chunk: 39

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 39
---
401(k) Plan”) for all eligible employees, effective May 1, 2016. The plan permits participants to contribute up to the amount allowable under federal limits of annual pre-tax compensation to the 401(k) Plan. Discretionary matching contributions to the 401(k) Plan are permitted in an amount equal to 50% of the first 6% of the employee’s taxable income up to a maximum of $3,000 per year. The Company accrued approximately $1.0 million, $0.7 million, and $0.5 million for matching contributions for the years ended December 31, 2024, 2023 and 2022, respectively.

F-30

EXHIBIT INDEX

    Exhibit

    Incorporated by Reference
      
    Filed

    Number
      
    Exhibit Description
     
    Form

    Date

    Number
     
    Herewith

    3.1
      
    Amended and Restated Certificate of Incorporation 
      
    8-K

    7/20/2018

    3.1

    3.2
      
    Amended and Restated Bylaws
      
    8-K

    12/12/2023

    3.1

    4.1
      
    Specimen Stock Certificate Evidencing the Shares of Common Stock
      
    S-1/A

    7/09/2018

    4.1

    4.2
     
    Description of Registered Securities
     
    10-K

    3/30/2021

    4.3

    10.1#
     
    Crinetics Pharmaceuticals, Inc. 2015 Stock Incentive Plan, as amended
     
    S-1/A

    7/09/2018

    10.1

    10.2#
     
    Form of stock option agreement under Crinetics Pharmaceuticals, Inc. 2015 Stock Incentive Plan, as amended
     
    S-1

    6/22/2018

    10.2

    10.3#
     
    Crinetics Pharmaceuticals, Inc. 2018 Incentive Award Plan 
     
    S-1/A

    7/09/2018

    10.3

    10.4#
     
    Form of stock option agreement under Crinetics Pharmaceuticals, Inc.